Group | Group Acute (n = 29) | Group Non-acute (n = 194) | P value |
---|---|---|---|
Hemorrhage location | 0.872 | ||
Location I, n (%) | 4(13.8) | 27(13.9) | |
Location II, n (%) | 23(79.3) | 158(81.4) | |
Location III, n (%) | 2(6.9) | 9(4.6) | |
Cause of Hemorrhage | 0.621 | ||
Tumor excision, n (%) | 19(65.5) | 127(65.5) | |
Biopsy, n (%) | 7(24.1) | 57(29.4) | |
Stent extraction and implantation, n (%) | 2(6.9) | 8(4.1) | |
Dilation and tearing, n (%) | 1(3.4) | 2(1.0) | |
Conventional hemostasis method, n (%) | 26(89.7) * | 194(100) | 0.002 |
Lung isolation approach | |||
Endotracheal tube isolation, n (%) | 8(21.6) * | 3(1.5) | 0.000 |
Endoscopic balloon isolation, n (%) | 4(23.5) * | 3(1.5) | 0.006 |
Intravenous infusion of hemostatic, n (%) | 25(86.2) * | 73(37.6) | 0.000 |
Blood loss volume, ml | 1198.28 ± 913.93* | 216.18 ± 162.16 | 0.000 |
Duration of therapy, mins | 93.90 ± 53.07 * | 67.80 ± 28.09 | 0.000 |